Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 44-798G - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Anti-EGFR Monoclonal Antibody (H9B4)
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- H9B4
- Vial size
- 100 µL
- Concentration
- Lot Dependent
- Storage
- -20°C
Submitted references HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone.
Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.
MUC1 stimulates EGFR expression and function in endometrial cancer.
EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer.
Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, Daignault-Newton S, El-Sawy L, Wilson SJ, Chou A, Ignatoski KW, Keller E, Thomas D, Nagrath S, Morgan T, Day ML
Cancer research 2017 Jan 1;77(1):74-85
Cancer research 2017 Jan 1;77(1):74-85
Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.
Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, Singh P, Chi YI, Wang C, Dong C, Li W, Tao M, Napier D, Shi Q, Deng J, Evers BM, Zhou BP
Nature communications 2017 Feb 15;8:14228
Nature communications 2017 Feb 15;8:14228
MUC1 stimulates EGFR expression and function in endometrial cancer.
Engel BJ, Bowser JL, Broaddus RR, Carson DD
Oncotarget 2016 May 31;7(22):32796-809
Oncotarget 2016 May 31;7(22):32796-809
EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer.
Choi SH, Mendrola JM, Lemmon MA
Oncogene 2007 Mar 8;26(11):1567-76
Oncogene 2007 Mar 8;26(11):1567-76
No comments: Submit comment
No validations: Submit validation data